PD-1 inhibitors have revolutionised cancer treatment over the last decade, with their success attributed to Keytruda and ...

The European Commission approved Johnson and Johnson’s Yuvanci as the first single-pill combination therapy for PAH.

The retrospective study presented at ESMO 2024 involved about 2,400 patients with stage 3 or 4 non-small cell lung cancer.

The first needle-free epinephrine nasal spray, Neffy by ARS Pharmaceuticals, represents a significant breakthrough in ...

Modalis Therapeutics has been awarded a rare paediatric disease designation by the US Food and Drug Administration (FDA) for ...

PureTech Health has obtained approval from the US Food and Drug Administration (FDA) for KarXT to treat schizophrenia in ...

SK pharmteco, a contract development and manufacturing organisation, has announced an investment of $260m to expand its small ...

LEO Pharma has submitted a New Drug Application (NDA) to China's National Medical Products Administration for Enstilar, ...

Medidata is a winner in the Innovation, and Product Launches categories in the 2024 Pharmaceutical Technology Excellence ...

The MediLedger Project utilises blockchain technology to tackle counterfeit drugs. The project uses blockchain to track and ...

Biocon has entered a partnership with Tabuk Pharmaceuticals for the commercialisation of glucagon-like peptide-1 (GLP-1) ...

The US Food and Drug Administration (FDA) has announced the approval of Sanofi and Regeneron’s interleukin (IL)-4 and IL-13 ...